OGN Organon Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 23
Relative Strength: Rel. Strength: 90
Relative Valuation: Rel. Valuation: 81
Relative Profitability: Rel. Profitability: 62

EPS in 2026 (TTM): $0.94

Last Report Period Date: Mar 31, 2026

As of June 2026, OGN's trailing twelve months (TTM) EPS stands at $0.94, according to the latest financial reports. In 2025, the company recorded an earnings per share (EPS) of $0.72, which represents a decrease compared to its EPS of $3.36 in 2024. OGN reported an EPS of $0.56 for the quarterly report ending on Mar 31, 2026.

OGN earnings history

Historical annual and quarterly earnings per share (EPS) data for Organon
EPS (TTM)
$0.94
EPS Growth YoY (Quarterly)
64.7%
EPS (Quarterly)
$0.56
EPS Growth (Quarterly)
170.9%

For 2025, Organon's EPS was $0.72, a decrease of 78.6% from $3.36 in 2024. For the quarter ending Mar 31, 2026, the EPS was $0.56, showing a 64.7% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is $0.94. In 2024, the annual EPS was $3.36, showing a decrease of 16.2% from 2023.

OGN earnings chart

OGN EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
64.7%
EPS growth YoY
-78.6%
EPS growth 3Y avg
-41.6%
EPS growth 5Y avg
-39%

Over the last 12 months, Organon has registered an EPS growth of 64.7% (YoY, quarterly). Over a three-year span, the company had an average EPS growth of -41.6% per year. Over the last 5 years, the company had an average EPS growth rate of -39%.

OGN Earnings Waterfall

Breakdown of revenue, profit and net income for Organon

OGN Earnings vs Peers

What are the earnings of OGN compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
OGN Organon & Co 14.26 -78.6% -41.6% -39%
OPK Opko Health Inc N/A -275% N/A N/A
ORGO Organogenesis Holdings Inc N/A 1,700% 10.1% 0%

All data is based on quarterly TTM periods, unless otherwise specified.